46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 23,9 | 27 | 43,3 | 60,5 |
EBITDA | 24,1 | 27,5 | 37,6 | 36,6 |
Short time liabilities | 261,7 | 321 | 523 | 62,9 |
Equity capital | 39 | 60,4 | 93,5 | 54,9 |
Operating profit (EBIT) | 24,1 | 27,5 | 37,6 | 36,6 |
Assets | 310,6 | 414,4 | 724,7 | 74,9 |
Net profit (loss) | 19 | 21,3 | 33,1 | 55,3 |
Cash | 0 | 12,1 | 75,4 | 522,5 |
Liabilities and provisions for liabilities | 271,6 | 354,1 | 631,3 | 78,3 |
Net income from sale | 571,2 | 650,3 | 944,8 | 45,3 |
Working assets | 293,2 | 390,9 | 677,8 | 73,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 48,7 | 35,3 | 35,4 | 0,1 |
Equity capital to total assets | 12,6 | 14,6 | 12,9 | -1,7 |
Gross profit margin | 4,2 | 4,1 | 4,6 | 0,5 |
EBITDA Margin | 4,2 | 4,2 | 4 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 167 | 180 | 202 | 22 |
Current financial liquidity indicator | 1.0797293186187744 | 1.1042085886001587 | 1.0738778114318848 | 0 |
Net dept to EBITDA | 3.756369113922119 | -0.44001588225364685 | -2.0045006275177 | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane